SAB Biotherapeutics Inc (SABS)
4.03
+0.01
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
SAB Biotherapeutics Price to Book Value: 0.6489 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.6489 |
| May 02, 2024 | 0.6472 |
| May 01, 2024 | 0.6601 |
| April 30, 2024 | 0.6907 |
| April 29, 2024 | 0.6746 |
| April 26, 2024 | 0.6843 |
| April 25, 2024 | 0.6456 |
| April 24, 2024 | 0.7084 |
| April 23, 2024 | 0.702 |
| April 22, 2024 | 0.7068 |
| April 19, 2024 | 0.6907 |
| April 18, 2024 | 0.7181 |
| April 17, 2024 | 0.7406 |
| April 16, 2024 | 0.7857 |
| April 15, 2024 | 0.7422 |
| April 12, 2024 | 0.7527 |
| April 11, 2024 | 0.7326 |
| April 10, 2024 | 0.7326 |
| April 09, 2024 | 0.7181 |
| April 08, 2024 | 0.7181 |
| April 05, 2024 | 0.6988 |
| April 04, 2024 | 0.7116 |
| April 03, 2024 | 0.7181 |
| April 02, 2024 | 0.7245 |
| April 01, 2024 | 0.6907 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.731 |
| March 27, 2024 | 0.6794 |
| March 26, 2024 | 0.6714 |
| March 25, 2024 | 0.6843 |
| March 22, 2024 | 0.7857 |
| March 21, 2024 | 0.7551 |
| March 20, 2024 | 0.7712 |
| March 19, 2024 | 0.7728 |
| March 18, 2024 | 0.8694 |
| March 15, 2024 | 0.8887 |
| March 14, 2024 | 0.966 |
| March 13, 2024 | 0.9322 |
| March 12, 2024 | 0.9434 |
| March 11, 2024 | 0.8839 |
| March 08, 2024 | 0.8629 |
| March 07, 2024 | 0.8565 |
| March 06, 2024 | 0.8517 |
| March 05, 2024 | 0.8034 |
| March 04, 2024 | 0.7003 |
| March 01, 2024 | 0.71 |
| February 29, 2024 | 0.718 |
| February 28, 2024 | 0.6794 |
| February 27, 2024 | 0.805 |
| February 26, 2024 | 0.8034 |
| February 23, 2024 | 0.7985 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6456
Minimum
Apr 25 2024
9.589
Maximum
Jan 03 2022
2.167
Average
1.642
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
| NovaBay Pharmaceuticals Inc | 2.094 |
| Protalix BioTherapeutics Inc | 2.481 |
Price to Book Value Related Metrics
| Price | 4.03 |
| Earnings Yield | -192.1% |
| Market Cap | 37.18M |